nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—Phenobarbital—CYP4B1—urinary bladder cancer	0.0305	1	CrCbGaD
Ethotoin—Lymphoma—Gemcitabine—urinary bladder cancer	0.0275	0.0497	CcSEcCtD
Ethotoin—Non-Hodgkin's lymphoma—Gemcitabine—urinary bladder cancer	0.0275	0.0497	CcSEcCtD
Ethotoin—SCN7A—prostate gland—urinary bladder cancer	0.0233	0.131	CbGeAlD
Ethotoin—CYP2C19—urine—urinary bladder cancer	0.0227	0.127	CbGeAlD
Ethotoin—Emotional distress—Fluorouracil—urinary bladder cancer	0.0223	0.0401	CcSEcCtD
Ethotoin—SCN9A—prostate gland—urinary bladder cancer	0.0183	0.103	CbGeAlD
Ethotoin—SCN4A—prostate gland—urinary bladder cancer	0.0163	0.0915	CbGeAlD
Ethotoin—Lymphoma—Methotrexate—urinary bladder cancer	0.0141	0.0254	CcSEcCtD
Ethotoin—Nystagmus—Fluorouracil—urinary bladder cancer	0.0132	0.0239	CcSEcCtD
Ethotoin—SCN7A—female reproductive system—urinary bladder cancer	0.0127	0.0715	CbGeAlD
Ethotoin—SCN3A—prostate gland—urinary bladder cancer	0.0127	0.0712	CbGeAlD
Ethotoin—Chest pain—Valrubicin—urinary bladder cancer	0.0123	0.0222	CcSEcCtD
Ethotoin—Numbness—Fluorouracil—urinary bladder cancer	0.0114	0.0206	CcSEcCtD
Ethotoin—SCN4A—renal system—urinary bladder cancer	0.0111	0.0624	CbGeAlD
Ethotoin—Sensory loss—Fluorouracil—urinary bladder cancer	0.0109	0.0197	CcSEcCtD
Ethotoin—Numbness—Etoposide—urinary bladder cancer	0.00991	0.0179	CcSEcCtD
Ethotoin—Sensory loss—Etoposide—urinary bladder cancer	0.00948	0.0171	CcSEcCtD
Ethotoin—Body temperature increased—Valrubicin—urinary bladder cancer	0.00931	0.0168	CcSEcCtD
Ethotoin—SCN3A—renal system—urinary bladder cancer	0.00863	0.0485	CbGeAlD
Ethotoin—Body temperature increased—Carboplatin—urinary bladder cancer	0.00862	0.0156	CcSEcCtD
Ethotoin—Asthenia—Valrubicin—urinary bladder cancer	0.00845	0.0152	CcSEcCtD
Ethotoin—Diarrhoea—Valrubicin—urinary bladder cancer	0.00806	0.0145	CcSEcCtD
Ethotoin—Ataxia—Thiotepa—urinary bladder cancer	0.00781	0.0141	CcSEcCtD
Ethotoin—Dizziness—Valrubicin—urinary bladder cancer	0.00779	0.014	CcSEcCtD
Ethotoin—Vomiting—Valrubicin—urinary bladder cancer	0.00749	0.0135	CcSEcCtD
Ethotoin—SCN7A—lymph node—urinary bladder cancer	0.00744	0.0418	CbGeAlD
Ethotoin—Rash—Valrubicin—urinary bladder cancer	0.00743	0.0134	CcSEcCtD
Ethotoin—Dermatitis—Valrubicin—urinary bladder cancer	0.00742	0.0134	CcSEcCtD
Ethotoin—Headache—Valrubicin—urinary bladder cancer	0.00738	0.0133	CcSEcCtD
Ethotoin—SCN2A—vagina—urinary bladder cancer	0.00712	0.04	CbGeAlD
Ethotoin—Nausea—Valrubicin—urinary bladder cancer	0.007	0.0126	CcSEcCtD
Ethotoin—Fatigue—Mitomycin—urinary bladder cancer	0.007	0.0126	CcSEcCtD
Ethotoin—SCN3A—female reproductive system—urinary bladder cancer	0.00692	0.0389	CbGeAlD
Ethotoin—Ataxia—Fluorouracil—urinary bladder cancer	0.00646	0.0116	CcSEcCtD
Ethotoin—Nystagmus—Epirubicin—urinary bladder cancer	0.00645	0.0116	CcSEcCtD
Ethotoin—Body temperature increased—Mitomycin—urinary bladder cancer	0.00641	0.0116	CcSEcCtD
Ethotoin—SCN3A—vagina—urinary bladder cancer	0.00625	0.0351	CbGeAlD
Ethotoin—SCN5A—vagina—urinary bladder cancer	0.00624	0.035	CbGeAlD
Ethotoin—Nystagmus—Doxorubicin—urinary bladder cancer	0.00597	0.0108	CcSEcCtD
Ethotoin—SCN9A—lymph node—urinary bladder cancer	0.00583	0.0328	CbGeAlD
Ethotoin—Asthenia—Mitomycin—urinary bladder cancer	0.00582	0.0105	CcSEcCtD
Ethotoin—Diarrhoea—Mitomycin—urinary bladder cancer	0.00555	0.01	CcSEcCtD
Ethotoin—Dizziness—Mitomycin—urinary bladder cancer	0.00537	0.00968	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.00534	0.00962	CcSEcCtD
Ethotoin—Vomiting—Mitomycin—urinary bladder cancer	0.00516	0.00931	CcSEcCtD
Ethotoin—Rash—Mitomycin—urinary bladder cancer	0.00512	0.00923	CcSEcCtD
Ethotoin—Dermatitis—Mitomycin—urinary bladder cancer	0.00511	0.00922	CcSEcCtD
Ethotoin—Headache—Mitomycin—urinary bladder cancer	0.00508	0.00917	CcSEcCtD
Ethotoin—Nausea—Mitomycin—urinary bladder cancer	0.00482	0.00869	CcSEcCtD
Ethotoin—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00473	0.00853	CcSEcCtD
Ethotoin—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00457	0.00824	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00456	0.00822	CcSEcCtD
Ethotoin—SCN10A—lymph node—urinary bladder cancer	0.00444	0.0249	CbGeAlD
Ethotoin—Lymphadenopathy—Methotrexate—urinary bladder cancer	0.00419	0.00755	CcSEcCtD
Ethotoin—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00411	0.0074	CcSEcCtD
Ethotoin—SCN3A—lymph node—urinary bladder cancer	0.00405	0.0227	CbGeAlD
Ethotoin—CYP2C19—vagina—urinary bladder cancer	0.00402	0.0226	CbGeAlD
Ethotoin—Lymphadenopathy—Epirubicin—urinary bladder cancer	0.00392	0.00707	CcSEcCtD
Ethotoin—Erythema multiforme—Etoposide—urinary bladder cancer	0.0039	0.00704	CcSEcCtD
Ethotoin—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.00363	0.00654	CcSEcCtD
Ethotoin—Chest pain—Gemcitabine—urinary bladder cancer	0.00358	0.00646	CcSEcCtD
Ethotoin—Chest pain—Fluorouracil—urinary bladder cancer	0.00352	0.00635	CcSEcCtD
Ethotoin—Fatigue—Thiotepa—urinary bladder cancer	0.00352	0.00635	CcSEcCtD
Ethotoin—Ataxia—Methotrexate—urinary bladder cancer	0.00336	0.00606	CcSEcCtD
Ethotoin—Diplopia—Epirubicin—urinary bladder cancer	0.00334	0.00603	CcSEcCtD
Ethotoin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00323	0.00582	CcSEcCtD
Ethotoin—Ataxia—Epirubicin—urinary bladder cancer	0.00314	0.00567	CcSEcCtD
Ethotoin—Insomnia—Gemcitabine—urinary bladder cancer	0.0031	0.0056	CcSEcCtD
Ethotoin—Diplopia—Doxorubicin—urinary bladder cancer	0.00309	0.00558	CcSEcCtD
Ethotoin—Chest pain—Etoposide—urinary bladder cancer	0.00306	0.00552	CcSEcCtD
Ethotoin—Insomnia—Fluorouracil—urinary bladder cancer	0.00305	0.00551	CcSEcCtD
Ethotoin—Fatigue—Gemcitabine—urinary bladder cancer	0.00296	0.00534	CcSEcCtD
Ethotoin—Asthenia—Thiotepa—urinary bladder cancer	0.00293	0.00528	CcSEcCtD
Ethotoin—Ataxia—Doxorubicin—urinary bladder cancer	0.00291	0.00525	CcSEcCtD
Ethotoin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00279	0.00504	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00273	0.00492	CcSEcCtD
Ethotoin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00271	0.00489	CcSEcCtD
Ethotoin—Dizziness—Thiotepa—urinary bladder cancer	0.0027	0.00487	CcSEcCtD
Ethotoin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00267	0.00481	CcSEcCtD
Ethotoin—Vomiting—Thiotepa—urinary bladder cancer	0.00259	0.00468	CcSEcCtD
Ethotoin—Rash—Thiotepa—urinary bladder cancer	0.00257	0.00464	CcSEcCtD
Ethotoin—Dermatitis—Thiotepa—urinary bladder cancer	0.00257	0.00464	CcSEcCtD
Ethotoin—Headache—Thiotepa—urinary bladder cancer	0.00256	0.00461	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00255	0.00461	CcSEcCtD
Ethotoin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00253	0.00456	CcSEcCtD
Ethotoin—Fatigue—Etoposide—urinary bladder cancer	0.00253	0.00456	CcSEcCtD
Ethotoin—Asthenia—Gemcitabine—urinary bladder cancer	0.00246	0.00444	CcSEcCtD
Ethotoin—Nausea—Thiotepa—urinary bladder cancer	0.00242	0.00437	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00236	0.00426	CcSEcCtD
Ethotoin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00235	0.00424	CcSEcCtD
Ethotoin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00234	0.00421	CcSEcCtD
Ethotoin—Body temperature increased—Etoposide—urinary bladder cancer	0.00232	0.00418	CcSEcCtD
Ethotoin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00231	0.00417	CcSEcCtD
Ethotoin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.0023	0.00415	CcSEcCtD
Ethotoin—Asthenia—Cisplatin—urinary bladder cancer	0.0023	0.00414	CcSEcCtD
Ethotoin—Dizziness—Fluorouracil—urinary bladder cancer	0.00223	0.00403	CcSEcCtD
Ethotoin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00219	0.00395	CcSEcCtD
Ethotoin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00219	0.00394	CcSEcCtD
Ethotoin—Vomiting—Gemcitabine—urinary bladder cancer	0.00218	0.00394	CcSEcCtD
Ethotoin—Rash—Gemcitabine—urinary bladder cancer	0.00216	0.0039	CcSEcCtD
Ethotoin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00216	0.0039	CcSEcCtD
Ethotoin—Headache—Gemcitabine—urinary bladder cancer	0.00215	0.00388	CcSEcCtD
Ethotoin—Vomiting—Fluorouracil—urinary bladder cancer	0.00215	0.00387	CcSEcCtD
Ethotoin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00213	0.00384	CcSEcCtD
Ethotoin—Rash—Fluorouracil—urinary bladder cancer	0.00213	0.00384	CcSEcCtD
Ethotoin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00213	0.00383	CcSEcCtD
Ethotoin—Headache—Fluorouracil—urinary bladder cancer	0.00211	0.00381	CcSEcCtD
Ethotoin—Asthenia—Etoposide—urinary bladder cancer	0.0021	0.00379	CcSEcCtD
Ethotoin—Nausea—Gemcitabine—urinary bladder cancer	0.00204	0.00368	CcSEcCtD
Ethotoin—Vomiting—Cisplatin—urinary bladder cancer	0.00203	0.00367	CcSEcCtD
Ethotoin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00202	0.00365	CcSEcCtD
Ethotoin—Rash—Cisplatin—urinary bladder cancer	0.00202	0.00364	CcSEcCtD
Ethotoin—Dermatitis—Cisplatin—urinary bladder cancer	0.00202	0.00364	CcSEcCtD
Ethotoin—Diarrhoea—Etoposide—urinary bladder cancer	0.00201	0.00362	CcSEcCtD
Ethotoin—Nausea—Fluorouracil—urinary bladder cancer	0.002	0.00362	CcSEcCtD
Ethotoin—Dizziness—Etoposide—urinary bladder cancer	0.00194	0.0035	CcSEcCtD
Ethotoin—Nausea—Cisplatin—urinary bladder cancer	0.0019	0.00343	CcSEcCtD
Ethotoin—Vomiting—Etoposide—urinary bladder cancer	0.00186	0.00336	CcSEcCtD
Ethotoin—Rash—Etoposide—urinary bladder cancer	0.00185	0.00333	CcSEcCtD
Ethotoin—Dermatitis—Etoposide—urinary bladder cancer	0.00185	0.00333	CcSEcCtD
Ethotoin—Headache—Etoposide—urinary bladder cancer	0.00184	0.00331	CcSEcCtD
Ethotoin—Chest pain—Methotrexate—urinary bladder cancer	0.00183	0.0033	CcSEcCtD
Ethotoin—Nausea—Etoposide—urinary bladder cancer	0.00174	0.00314	CcSEcCtD
Ethotoin—Chest pain—Epirubicin—urinary bladder cancer	0.00171	0.00309	CcSEcCtD
Ethotoin—Insomnia—Methotrexate—urinary bladder cancer	0.00159	0.00286	CcSEcCtD
Ethotoin—Chest pain—Doxorubicin—urinary bladder cancer	0.00159	0.00286	CcSEcCtD
Ethotoin—Fatigue—Methotrexate—urinary bladder cancer	0.00151	0.00273	CcSEcCtD
Ethotoin—Insomnia—Epirubicin—urinary bladder cancer	0.00149	0.00268	CcSEcCtD
Ethotoin—Fatigue—Epirubicin—urinary bladder cancer	0.00142	0.00256	CcSEcCtD
Ethotoin—Body temperature increased—Methotrexate—urinary bladder cancer	0.00139	0.0025	CcSEcCtD
Ethotoin—Insomnia—Doxorubicin—urinary bladder cancer	0.00138	0.00248	CcSEcCtD
Ethotoin—Fatigue—Doxorubicin—urinary bladder cancer	0.00131	0.00236	CcSEcCtD
Ethotoin—Body temperature increased—Epirubicin—urinary bladder cancer	0.0013	0.00234	CcSEcCtD
Ethotoin—Asthenia—Methotrexate—urinary bladder cancer	0.00126	0.00227	CcSEcCtD
Ethotoin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.0012	0.00217	CcSEcCtD
Ethotoin—Diarrhoea—Methotrexate—urinary bladder cancer	0.0012	0.00217	CcSEcCtD
Ethotoin—Asthenia—Epirubicin—urinary bladder cancer	0.00118	0.00213	CcSEcCtD
Ethotoin—Dizziness—Methotrexate—urinary bladder cancer	0.00116	0.00209	CcSEcCtD
Ethotoin—Diarrhoea—Epirubicin—urinary bladder cancer	0.00112	0.00203	CcSEcCtD
Ethotoin—Vomiting—Methotrexate—urinary bladder cancer	0.00112	0.00201	CcSEcCtD
Ethotoin—Rash—Methotrexate—urinary bladder cancer	0.00111	0.002	CcSEcCtD
Ethotoin—Dermatitis—Methotrexate—urinary bladder cancer	0.00111	0.00199	CcSEcCtD
Ethotoin—Headache—Methotrexate—urinary bladder cancer	0.0011	0.00198	CcSEcCtD
Ethotoin—Asthenia—Doxorubicin—urinary bladder cancer	0.00109	0.00197	CcSEcCtD
Ethotoin—Dizziness—Epirubicin—urinary bladder cancer	0.00109	0.00196	CcSEcCtD
Ethotoin—Vomiting—Epirubicin—urinary bladder cancer	0.00104	0.00188	CcSEcCtD
Ethotoin—Nausea—Methotrexate—urinary bladder cancer	0.00104	0.00188	CcSEcCtD
Ethotoin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00104	0.00188	CcSEcCtD
Ethotoin—Rash—Epirubicin—urinary bladder cancer	0.00104	0.00187	CcSEcCtD
Ethotoin—Dermatitis—Epirubicin—urinary bladder cancer	0.00104	0.00187	CcSEcCtD
Ethotoin—Headache—Epirubicin—urinary bladder cancer	0.00103	0.00186	CcSEcCtD
Ethotoin—Dizziness—Doxorubicin—urinary bladder cancer	0.00101	0.00181	CcSEcCtD
Ethotoin—Nausea—Epirubicin—urinary bladder cancer	0.000976	0.00176	CcSEcCtD
Ethotoin—Vomiting—Doxorubicin—urinary bladder cancer	0.000967	0.00174	CcSEcCtD
Ethotoin—Rash—Doxorubicin—urinary bladder cancer	0.000959	0.00173	CcSEcCtD
Ethotoin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000958	0.00173	CcSEcCtD
Ethotoin—Headache—Doxorubicin—urinary bladder cancer	0.000952	0.00172	CcSEcCtD
Ethotoin—Nausea—Doxorubicin—urinary bladder cancer	0.000903	0.00163	CcSEcCtD
Ethotoin—SCN1A—L1CAM interactions—EGFR—urinary bladder cancer	0.00079	0.00333	CbGpPWpGaD
Ethotoin—SCN10A—L1CAM interactions—EGFR—urinary bladder cancer	0.00079	0.00333	CbGpPWpGaD
Ethotoin—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00076	0.0032	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—NCOR1—urinary bladder cancer	0.000744	0.00314	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—ERBB2—urinary bladder cancer	0.000738	0.00311	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—CDK4—urinary bladder cancer	0.00072	0.00304	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—RHOA—urinary bladder cancer	0.00071	0.003	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—ERBB2—urinary bladder cancer	0.000657	0.00277	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—PPARG—urinary bladder cancer	0.000654	0.00276	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—RHOA—urinary bladder cancer	0.00065	0.00274	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000649	0.00274	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—CDK4—urinary bladder cancer	0.000642	0.00271	CbGpPWpGaD
Ethotoin—SCN5A—L1CAM interactions—SRC—urinary bladder cancer	0.000634	0.00267	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—MMP9—urinary bladder cancer	0.000633	0.00267	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—CREBBP—urinary bladder cancer	0.000628	0.00265	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—NCOR1—urinary bladder cancer	0.000602	0.00254	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—ERBB2—urinary bladder cancer	0.000601	0.00254	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.000598	0.00252	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00059	0.00249	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—CDK4—urinary bladder cancer	0.000587	0.00248	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—SRC—urinary bladder cancer	0.000583	0.00246	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—PPARG—urinary bladder cancer	0.000583	0.00246	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—NCOR1—urinary bladder cancer	0.000576	0.00243	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—RHOA—urinary bladder cancer	0.000569	0.0024	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—MMP9—urinary bladder cancer	0.000564	0.00238	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—CREBBP—urinary bladder cancer	0.00056	0.00236	CbGpPWpGaD
Ethotoin—SCN5A—L1CAM interactions—EGFR—urinary bladder cancer	0.000556	0.00234	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—NCOR1—urinary bladder cancer	0.000553	0.00233	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—NCOR1—urinary bladder cancer	0.000553	0.00233	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—PPARG—urinary bladder cancer	0.000533	0.00225	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—NCOR1—urinary bladder cancer	0.000533	0.00225	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—NCOR1—urinary bladder cancer	0.000533	0.00225	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—ERBB2—urinary bladder cancer	0.000526	0.00222	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—RHOA—urinary bladder cancer	0.000525	0.00222	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—SRC—urinary bladder cancer	0.00052	0.00219	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—MMP9—urinary bladder cancer	0.000516	0.00218	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000516	0.00217	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—CREBBP—urinary bladder cancer	0.000512	0.00216	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—EGFR—urinary bladder cancer	0.000511	0.00216	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—RHOA—urinary bladder cancer	0.000507	0.00214	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—RHOA—urinary bladder cancer	0.000502	0.00212	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—ERBB2—urinary bladder cancer	0.000486	0.00205	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—KRAS—urinary bladder cancer	0.000483	0.00204	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—RHOA—urinary bladder cancer	0.000483	0.00204	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—RHOA—urinary bladder cancer	0.000483	0.00204	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000478	0.00202	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—SRC—urinary bladder cancer	0.000476	0.00201	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—CDK4—urinary bladder cancer	0.000475	0.002	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—ERBB2—urinary bladder cancer	0.000469	0.00198	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—RHOA—urinary bladder cancer	0.000465	0.00196	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—RHOA—urinary bladder cancer	0.000465	0.00196	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—ERBB2—urinary bladder cancer	0.000465	0.00196	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000464	0.00196	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—RHOA—urinary bladder cancer	0.000464	0.00196	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—EGFR—urinary bladder cancer	0.000456	0.00192	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—CDK4—urinary bladder cancer	0.000454	0.00192	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—MMP9—urinary bladder cancer	0.000451	0.0019	CbGpPWpGaD
Ethotoin—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000447	0.00189	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—ERBB2—urinary bladder cancer	0.000447	0.00189	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—ERBB2—urinary bladder cancer	0.000447	0.00189	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000442	0.00186	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CDK4—urinary bladder cancer	0.000436	0.00184	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—CDK4—urinary bladder cancer	0.000436	0.00184	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—PPARG—urinary bladder cancer	0.000431	0.00182	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—ERBB2—urinary bladder cancer	0.000431	0.00182	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—ERBB2—urinary bladder cancer	0.000431	0.00182	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—KRAS—urinary bladder cancer	0.00043	0.00182	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—ERBB2—urinary bladder cancer	0.000429	0.00181	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—EP300—urinary bladder cancer	0.000428	0.00181	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CDK4—urinary bladder cancer	0.000421	0.00177	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—CDK4—urinary bladder cancer	0.000421	0.00177	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—MMP9—urinary bladder cancer	0.000417	0.00176	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—EGFR—urinary bladder cancer	0.000417	0.00176	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—SRC—urinary bladder cancer	0.000416	0.00176	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—CREBBP—urinary bladder cancer	0.000414	0.00175	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—PPARG—urinary bladder cancer	0.000413	0.00174	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—HRAS—urinary bladder cancer	0.000411	0.00173	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—MMP9—urinary bladder cancer	0.000402	0.0017	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—MMP9—urinary bladder cancer	0.000399	0.00168	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—PPARG—urinary bladder cancer	0.000396	0.00167	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—PPARG—urinary bladder cancer	0.000396	0.00167	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—CREBBP—urinary bladder cancer	0.000396	0.00167	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—KRAS—urinary bladder cancer	0.000394	0.00166	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—SRC—urinary bladder cancer	0.000385	0.00162	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—MMP9—urinary bladder cancer	0.000383	0.00162	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—MMP9—urinary bladder cancer	0.000383	0.00162	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—PPARG—urinary bladder cancer	0.000382	0.00161	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—PPARG—urinary bladder cancer	0.000382	0.00161	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—EP300—urinary bladder cancer	0.000382	0.00161	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—CREBBP—urinary bladder cancer	0.000381	0.00161	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CREBBP—urinary bladder cancer	0.000381	0.00161	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—NCOR1—urinary bladder cancer	0.000375	0.00158	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—RHOA—urinary bladder cancer	0.000375	0.00158	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—SRC—urinary bladder cancer	0.000371	0.00157	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—MMP9—urinary bladder cancer	0.00037	0.00156	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—MMP9—urinary bladder cancer	0.00037	0.00156	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—MMP9—urinary bladder cancer	0.000368	0.00155	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—SRC—urinary bladder cancer	0.000368	0.00155	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CREBBP—urinary bladder cancer	0.000367	0.00155	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—CREBBP—urinary bladder cancer	0.000367	0.00155	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—HRAS—urinary bladder cancer	0.000366	0.00154	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—EGFR—urinary bladder cancer	0.000365	0.00154	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000359	0.00151	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—RHOA—urinary bladder cancer	0.000359	0.00151	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—SRC—urinary bladder cancer	0.000353	0.00149	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—SRC—urinary bladder cancer	0.000353	0.00149	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—EP300—urinary bladder cancer	0.000349	0.00147	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—TNF—urinary bladder cancer	0.000347	0.00147	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—ERBB2—urinary bladder cancer	0.000347	0.00146	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000345	0.00146	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—KRAS—urinary bladder cancer	0.000345	0.00145	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—RHOA—urinary bladder cancer	0.000344	0.00145	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—RHOA—urinary bladder cancer	0.000344	0.00145	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—SRC—urinary bladder cancer	0.000341	0.00144	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—SRC—urinary bladder cancer	0.000341	0.00144	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—SRC—urinary bladder cancer	0.000339	0.00143	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—EGFR—urinary bladder cancer	0.000337	0.00142	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—HRAS—urinary bladder cancer	0.000335	0.00141	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—RHOA—urinary bladder cancer	0.000332	0.0014	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—RHOA—urinary bladder cancer	0.000332	0.0014	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—ERBB2—urinary bladder cancer	0.000332	0.0014	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—RHOA—urinary bladder cancer	0.000327	0.00138	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—EGFR—urinary bladder cancer	0.000325	0.00137	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—EGFR—urinary bladder cancer	0.000322	0.00136	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000321	0.00136	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—ERBB2—urinary bladder cancer	0.000319	0.00135	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—ERBB2—urinary bladder cancer	0.000319	0.00135	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—KRAS—urinary bladder cancer	0.000318	0.00134	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000317	0.00134	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—EGFR—urinary bladder cancer	0.00031	0.00131	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—EGFR—urinary bladder cancer	0.00031	0.00131	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—TNF—urinary bladder cancer	0.00031	0.00131	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—ERBB2—urinary bladder cancer	0.000307	0.0013	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—ERBB2—urinary bladder cancer	0.000307	0.0013	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—KRAS—urinary bladder cancer	0.000307	0.0013	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—KRAS—urinary bladder cancer	0.000305	0.00128	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—ERBB2—urinary bladder cancer	0.000303	0.00128	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—EGFR—urinary bladder cancer	0.000299	0.00126	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—EGFR—urinary bladder cancer	0.000299	0.00126	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MMP9—urinary bladder cancer	0.000298	0.00126	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—EGFR—urinary bladder cancer	0.000297	0.00125	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CDK4—urinary bladder cancer	0.000296	0.00125	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000295	0.00125	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—HRAS—urinary bladder cancer	0.000293	0.00124	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—KRAS—urinary bladder cancer	0.000293	0.00123	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—KRAS—urinary bladder cancer	0.000293	0.00123	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000291	0.00123	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MMP9—urinary bladder cancer	0.000285	0.0012	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—TNF—urinary bladder cancer	0.000283	0.00119	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—EP300—urinary bladder cancer	0.000282	0.00119	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—KRAS—urinary bladder cancer	0.000282	0.00119	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—KRAS—urinary bladder cancer	0.000282	0.00119	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—KRAS—urinary bladder cancer	0.000281	0.00119	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—SRC—urinary bladder cancer	0.000274	0.00116	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MMP9—urinary bladder cancer	0.000274	0.00115	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MMP9—urinary bladder cancer	0.000274	0.00115	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—HRAS—urinary bladder cancer	0.000271	0.00114	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—EP300—urinary bladder cancer	0.00027	0.00114	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—PPARG—urinary bladder cancer	0.000269	0.00113	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MMP9—urinary bladder cancer	0.000264	0.00111	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MMP9—urinary bladder cancer	0.000264	0.00111	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—SRC—urinary bladder cancer	0.000262	0.00111	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—HRAS—urinary bladder cancer	0.000261	0.0011	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MMP9—urinary bladder cancer	0.00026	0.0011	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—EP300—urinary bladder cancer	0.000259	0.00109	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—EP300—urinary bladder cancer	0.000259	0.00109	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—HRAS—urinary bladder cancer	0.000259	0.00109	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CREBBP—urinary bladder cancer	0.000258	0.00109	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—SRC—urinary bladder cancer	0.000252	0.00106	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—SRC—urinary bladder cancer	0.000252	0.00106	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—EP300—urinary bladder cancer	0.00025	0.00105	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—EP300—urinary bladder cancer	0.00025	0.00105	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—HRAS—urinary bladder cancer	0.000249	0.00105	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—HRAS—urinary bladder cancer	0.000249	0.00105	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—SRC—urinary bladder cancer	0.000243	0.00103	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—SRC—urinary bladder cancer	0.000243	0.00103	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—EGFR—urinary bladder cancer	0.000241	0.00101	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—HRAS—urinary bladder cancer	0.00024	0.00101	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—HRAS—urinary bladder cancer	0.00024	0.00101	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—SRC—urinary bladder cancer	0.00024	0.00101	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—HRAS—urinary bladder cancer	0.000239	0.00101	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—RHOA—urinary bladder cancer	0.000234	0.000985	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—EGFR—urinary bladder cancer	0.00023	0.000971	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—TNF—urinary bladder cancer	0.000229	0.000966	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—KRAS—urinary bladder cancer	0.000227	0.000959	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—EGFR—urinary bladder cancer	0.000221	0.000932	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—EGFR—urinary bladder cancer	0.000221	0.000932	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—TNF—urinary bladder cancer	0.000219	0.000924	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—KRAS—urinary bladder cancer	0.000217	0.000917	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—ERBB2—urinary bladder cancer	0.000216	0.000912	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—EGFR—urinary bladder cancer	0.000213	0.000899	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—EGFR—urinary bladder cancer	0.000213	0.000899	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—TNF—urinary bladder cancer	0.000211	0.000888	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—TNF—urinary bladder cancer	0.000211	0.000888	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—EGFR—urinary bladder cancer	0.00021	0.000886	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—KRAS—urinary bladder cancer	0.000209	0.000881	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—KRAS—urinary bladder cancer	0.000209	0.000881	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—TNF—urinary bladder cancer	0.000203	0.000856	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—TNF—urinary bladder cancer	0.000203	0.000856	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—KRAS—urinary bladder cancer	0.000201	0.000849	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—KRAS—urinary bladder cancer	0.000201	0.000849	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—KRAS—urinary bladder cancer	0.000198	0.000837	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000197	0.00083	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—HRAS—urinary bladder cancer	0.000193	0.000815	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000187	0.000787	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000187	0.000787	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MMP9—urinary bladder cancer	0.000185	0.000782	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—HRAS—urinary bladder cancer	0.000185	0.000779	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000184	0.000774	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—HRAS—urinary bladder cancer	0.000177	0.000749	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—HRAS—urinary bladder cancer	0.000177	0.000749	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—EP300—urinary bladder cancer	0.000176	0.000742	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—HRAS—urinary bladder cancer	0.000171	0.000722	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—HRAS—urinary bladder cancer	0.000171	0.000722	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—SRC—urinary bladder cancer	0.000171	0.000721	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000171	0.00072	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—HRAS—urinary bladder cancer	0.000169	0.000711	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	0.000154	0.000648	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—EGFR—urinary bladder cancer	0.00015	0.000632	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	0.000145	0.000612	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—TNF—urinary bladder cancer	0.000143	0.000602	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—KRAS—urinary bladder cancer	0.000142	0.000597	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	0.000141	0.000597	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—HRAS—urinary bladder cancer	0.00012	0.000508	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000113	0.000478	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TYMP—urinary bladder cancer	0.000113	0.000477	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000109	0.000458	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NAT2—urinary bladder cancer	0.000102	0.000431	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—RRM2—urinary bladder cancer	8.83e-05	0.000372	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ENO2—urinary bladder cancer	8.17e-05	0.000345	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	8.17e-05	0.000345	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.13e-05	0.000343	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	7.93e-05	0.000334	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.81e-05	0.000329	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NQO1—urinary bladder cancer	6.59e-05	0.000278	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.39e-05	0.00027	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.57e-05	0.000235	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	5.49e-05	0.000232	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.32e-05	0.000224	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TYMS—urinary bladder cancer	5.11e-05	0.000215	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5.05e-05	0.000213	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5.05e-05	0.000213	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GPX1—urinary bladder cancer	4.84e-05	0.000204	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.75e-05	0.0002	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	4.46e-05	0.000188	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.62e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.48e-05	0.000147	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.85e-05	0.00012	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.48e-05	0.000105	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.37e-05	9.99e-05	CbGpPWpGaD
